The Value of PD-L1 Expression as Predictive Biomarker in Metastatic Renal Cell Carcinoma Patients: A Meta-Analysis of Randomized Clinical Trials

Immune checkpoint inhibitors (ICIs) are soluble antibodies that have dramatically changed the outcomes including overall survival in a subset of kidney tumors, specifically in renal cell carcinoma (RCC). To date, there is no a single predictive biomarker approved to be used to select the patients th...

Descripción completa

Detalles Bibliográficos
Autores principales: Carretero-González, Alberto, Lora, David, Martín Sobrino, Isabel, Sáez Sanz, Irene, Bourlon, María T., Anido Herranz, Urbano, Martínez Chanzá, Nieves, Castellano, Daniel, de Velasco, Guillermo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409133/
https://www.ncbi.nlm.nih.gov/pubmed/32709062
http://dx.doi.org/10.3390/cancers12071945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409133/
https://www.ncbi.nlm.nih.gov/pubmed/32709062
http://dx.doi.org/10.3390/cancers12071945

Ejemplares similares